Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial
2014; Elsevier BV; Volume: 124; Issue: 26 Linguagem: Inglês
10.1182/blood-2014-03-563627
ISSN1528-0020
AutoresDieter Hoelzer, Jan Walewski, Hartmut Döhner, Andreas Viardot, Wolfgang Hiddemann, Karsten Spiekermann, Hubert Serve, Ulrich Dührsen, Andreas Hüttmann, Eckhard Thiel, Jolanta Dengler, Michael Kneba, Markus Schaich, Ingo G.H. Schmidt‐Wolf, Joachim Beck, Bernd Hertenstein, Albrecht Reichle, Katarzyna Domańska‐Czyż, Rainer Fietkau, Heinz‐August Horst, Harald Rieder, Stefan Schwartz, Thomas Burmeister, Nicola Gökbuget,
Tópico(s)Viral-associated cancers and disorders
ResumoKey Points Largest prospective trial for adult Burkitt lymphoma/leukemia patients. Substantial cure rates and high treatment-realization rates in all age groups.
Referência(s)